Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Journal of Medicinal Chemistry|September 26, 2025
Cellular Potency Optimization of Novel Heme-Binding Imidazo[5,1-b]thiazoles, Imidazo[1,5-a]pyridines and Pyrazines as Potent IDO1 Inhibitors Devoid of Cytochrome P450 InhibitionSylvaine Cren, Carina Lotz-Jenne, Thierry Kimmerlin, et al.Chemical Communications (Cambridge, England)|January 17, 2015
Immobilization of polyoxometalates in the Zr-based metal organic framework UiO-67William Salomon, Catherine Roch-Marchal, Pierre Mialane, et al.Bioorganic & Medicinal Chemistry Letters|October 28, 2017
Discovery and evaluation of Cav3.2-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.Bioorganic & Medicinal Chemistry Letters|December 25, 2012
Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffoldClaire-Lise Ciana, Romain Siegrist, Hamed Aissaoui, et al.Bioorganic & Medicinal Chemistry Letters|September 27, 2006
Inhibitors of Plasmepsin II-potential antimalarial agentsOlivier Corminboeuf, Guillaume Dunet, Mehdi Hafsi, et al.Cornea|November 8, 2012
Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: a pilot studyNikki Heidi Ong, Tracy L Purcell, Anne-Catherine Roch-Levecq, et al.Neuropharmacology|August 27, 2025
IDOR-1104-0086, a novel Kv7 channel activator with antiseizure effects in rodentsMelanie Kessler, Andreas Mühlemann, Malgorzata Anna Mis, et al.Chemical Communications (Cambridge, England)|August 5, 2020
Structure-directing role of immobilized polyoxometalates in the synthesis of porphyrinic Zr-based metal-organic frameworksMathis Duguet, Alex Lemarchand, Youven Benseghir, et al.The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistMarc Iglarz, Christoph Binkert, Keith Morrison, et al.Journal of Medicinal Chemistry|August 7, 2012
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonistMartin H Bolli, Christoph Boss, Christoph Binkert, et al.Pageof 9